Glucosamine improves cardiac function following trauma-hemorrhage by increased proteinO-GlcNAcylation and attenuation of NF-κB signaling

American Journal of Physiology - Heart and Circulatory Physiology - Tập 296 Số 2 - Trang H515-H523 - 2009
Luyun Zou1, Shaolong Yang, Voraratt Champattanachai, Shunhua Hu, Irshad H. Chaudry, Richard B. Marchase, John C. Chatham
1University of Alabama at Birmingham, Birmingham, AL, USA;

Tóm tắt

We have previously demonstrated that in a rat model of trauma-hemorrhage (T-H), glucosamine administration during resuscitation improved cardiac function, reduced circulating levels of inflammatory cytokines, and increased tissue levels of O-linked N-acetylglucosamine ( O-GlcNAc) on proteins. The mechanism(s) by which glucosamine mediated its protective effect were not determined; therefore, the goal of this study was to test the hypothesis that glucosamine treatment attenuated the activation of the nuclear factor-κB (NF-κB) signaling pathway in the heart via an increase in protein O-GlcNAc levels. Fasted male rats were subjected to T-H by bleeding to a mean arterial blood pressure of 40 mmHg for 90 min followed by resuscitation. Glucosamine treatment during resuscitation significantly attenuated the T-H-induced increase in cardiac levels of TNF-α and IL-6 mRNA, IκB-α phosphorylation, NF-κB, NF-κB DNA binding activity, ICAM-1, and MPO activity. LPS (2 μg/ml) increased the levels of IκB-α phosphorylation, TNF-α, ICAM-1, and NF-κB in primary cultured cardiomyocytes, which was significantly attenuated by glucosamine treatment and overexpression of O-GlcNAc transferase; both interventions also significantly increased O-GlcNAc levels. In contrast, the transfection of neonatal rat ventricular myocytes with OGT small-interfering RNA decreased O-GlcNAc transferase and O-GlcNAc levels and enhanced the LPS-induced increase in IκB-α phosphorylation. Glucosamine treatment of macrophage cell line RAW 264.7 also increased O-GlcNAc levels and attenuated the LPS-induced activation of NF-κB. These results demonstrate that the modulation of O-GlcNAc levels alters the response of cardiomyocytes to the activation of the NF-κB pathway, which may contribute to the glucosamine-mediated improvement in cardiac function following hemorrhagic shock.

Từ khóa


Tài liệu tham khảo

10.1016/S1072-7515(98)00082-9

10.1007/s00268-004-2052-4

10.1097/00024382-200014020-00001

10.1016/j.amjsurg.2005.11.006

10.1152/ajpcell.00456.2007

10.1152/ajpcell.00456.2007

10.1152/ajpcell.00162.2006

10.1097/SHK.0b013e3181598bad

10.1074/jbc.270.32.18961

10.1097/01.shk.0000191341.31530.5e

10.1152/ajpendo.90281.2008

10.1006/cyto.2001.0861

10.1016/j.cardiores.2006.07.018

10.1152/ajpheart.01091.2006

Hierholzer C, Billiar TR.Molecular mechanisms in the early phase of hemorrhagic shock.Langenbecks Arch Surg236: 302–308, 2001.

10.1074/jbc.M107167200

10.1152/ajpheart.00162.2003

10.2337/diabetes.51.4.1146

10.1161/CIRCULATIONAHA.107.730515

10.1172/JCI118090

10.1016/j.injury.2004.12.037

Liang Y, Zhou Y, Shen P.NF-kappaB and its regulation on the immune system.Cell Mol Immunol1: 343–350, 2004.

10.1152/ajpheart.00285.2007

10.1016/j.yjmcc.2005.11.003

10.1152/ajpendo.00274.2005

Love DC, Hanover JA.The hexosamine signaling pathway: deciphering the “O-GlcNAc code”.Sci STKE2005: re13, 2005.

10.1074/jbc.M413819200

10.1042/BJ20041506

10.1096/fj.99-0645com

10.1152/ajpregu.1998.274.3.R577

10.1006/jmcc.1997.0506

10.1126/science.1126867

Not LG, Brocks CA, Marchase RB, Chatham JC.O-GlcNAc agonist treatment improves survival, reduces inflammation and organ damage 24 hours after trauma-hemorrhage in rats (Abstract).FASEB J22: 1227, 2008.

10.2337/diabetes.51.12.3461

Peng R, Chang C, Gilmore D, Bongard F.Epidemiology of immediate and early trauma deaths at an urban level I trauma center.Am Surg64: 950–954, 1998.

10.1016/j.bmc.2005.09.013

10.1007/s002689900067

10.1097/00005373-199904000-00004

10.1097/00005373-199502000-00006

10.1097/00024382-200014030-00019

Shaw P, Freeman J, Bovey R, Iggo R.Regulation of specific DNA binding by p53: evidence for a role forO-glycosylation and charged residues at the carboxy-terminus.Oncogene12: 921–930, 1996.

10.1002/jcb.20676

10.1016/j.cell.2007.03.022

10.1111/j.1399-6576.2006.01207.x

10.1016/S0006-291X(03)00175-X

10.1152/ajpheart.01259.2007

10.1152/ajpheart.00624.2003

10.1097/01.shk.0000209563.07693.db

10.1016/j.bbagen.2004.03.016

10.1074/jbc.M403773200

10.1016/S0092-8674(03)00974-7

10.1097/01.shk.0000245031.31859.29